Healthcare
Principia backs Trifarma MBO
Deal is the first majority acquisition for the GP's healthcare-dedicated vehicle, Principia III Health
Creathor and MTIP lead €14m round for Blueprint
Existing investors, including Inventure and Pontos Group, will also participate
Ufenau buys Karthaus
Horse breeder and billionaire Andreas Jacobs, the duke of Croy and CEO Victor Baltus will also hold shares
Ekkio Capital exits Amatsigroup
Amatsigroup is said to be valued at €130m in the transaction, non-inclusive of its residual debt
1717 Life Science Ventures announces €50m venture fund
1717 will now begin fundraising and expects to hold a final close within six to eight months
Bain, Cinven in increased bid for Stada
Following a failed bid in June, the GPs launch a new offer with a 25 cents increase
MB Rahastot sells Cityterveys to Synlab
Divestment comes from the GP's buyout vehicle, MB Equity Fund IV, which held a final close on €260m
Gimv invests €15m in Arseus Medical
GP will draw capital for the transaction from its €150m Health & Care Fund, closed in March 2014
Bain, Cinven to bid again for Stada as CEO resigns
Stada CEO Matthias Wiedenfels has resigned today and will be replaced by Engelbert Coster Tjeenk Willink
Sun sells Nextpharma to Capvest
Sun says it strengthened senior management and optimised the manufacturing processes during its tenure
BioGeneration Ventures holds €66m close for Fund III
Having exceeded its original €50m target, the vehicle is aiming for a final close on €75m by year-end
Cobe buys Völker from Hill-Rom
End of a five-year holding period for Hill-Rom, which acquired Völker for $85m in February 2012
Bain and Cinven's Stada take-private bid fails
Offer narrowly misses the minimum acceptance condition, with 65.2% of Stada shares tendered
Idinvest in €12m round for M2i
Idinvest Growth Fund II was launched last year and held a first close on €250m in November
CM-CIC backs Le Normandy and Clinique Développement merger
CM-CIC started backing the Le Normandy group in 2000, structuring a €9.3m financing round
EQT buys 20% stake in Ottobock
GP will use capital from EQT VII to make the investment, based on a €3.15bn EV
BGF injects £3.85m into Dolphin Homes
Deal is the 12th transaction in 2017 for the UK-based growth capital investor
Innogest, Invitalia in €8.4m series-A for GreenBone Ortho
Luxembourg-based investment holding Helsinn Group led the funding round with a €2m injection
Gilde Buy Out Partners acquires Oystershell
GP is currently investing from its latest buyout vehicle, Gilde Fund V, which closed last year
TVM leads €25m series-A for Centogene
Backers include Deutsche Private Equity, Careventures and CIC Capital
Medicxi launches £300m late-stage fund
New vehicle will invest €10-25m in private or public European biotechnology businesses
Intera-backed Silmäasema raises €35m in IPO
Company will raise €35m from the offering, while the sellers, including Intera, will reap €30m
Charterhouse takes majority stake in Serb
Deal will be the first ever buyout for the Belgian speciality pharmaceuticals group
Eurazeo PME to acquire 80% of In'Tech Medical for €78m
Eurazeo is taking over from TCR Capital, which had secured a majority stake in In'Tech in 2012